OQROStart free trial
Politician trade (House)

Abbott Laboratories (ABT): Rep. Byron Donalds (FL19) disclosed a sale $1K–$15K

Rep. Byron Donalds (FL19) disclosed a sale of Abbott Laboratories in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
34 days
Disclosure lag
Traded
Dec 4, 2025
Disclosed
Jan 7, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  2. Oct 6, 2025FDARecall: Eterna SCS IPG (Implantable Pulse Generator), Model Number 32400
  3. Oct 6, 2025FDARecall: Liberta RC DBS IPG (Implantable Pulse Generator), Model Number 62400
  4. Oct 6, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  5. Oct 15, 2025Company filing · Form 8-K · ResultsReported its results
  6. Oct 29, 2025FDAFDA device clearance: Seguin Annuloplasty Ring
  7. Nov 5, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  8. Nov 13, 2025FDARecall: Alinity ci-series System Control Module (SCM), REF: 03R70-01, 03R70-20
  9. Nov 13, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  10. Nov 18, 2025Company filing · Form 8-K · Temporary Suspension of Trading Under Registrant's Employee Benefit PlansSuspended trading under its employee plans
  11. Nov 18, 2025CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  12. Nov 19, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  13. Nov 24, 2025FDARecall: FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monit…
  14. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-DI code: 00357599844011 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
  15. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-DI code: 00357599843014 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
  16. Nov 24, 2025FDARecall: FreeStyle Libre 3 Plus Sensor REF 72080-01 UDI-DI code: 00357599819002 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glu…
  17. Nov 25, 2025InsiderOfficer sold ~$203K of ABT shares in the open market
  18. Dec 3, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 10.1%
  19. Dec 4, 2025 · this disclosureCongressDisclosed sale of ABT — reported range $1,001 - $15,000

What came next

  1. Dec 4, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  2. Dec 8, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  3. Dec 12, 2025Company filing · Form 8-K · Executive change, Bylaws or charterChanged a top executive or board member, and changed its bylaws, charter or fiscal year“On December 12, 2025, Nita Ahuja, M.D. was named to the Abbott Laboratories’ (“Abbott”) Board of Directors.”
  4. Dec 17, 2025FDAFDA device clearance: Amplatzer Piccolo™ Delivery System (9-PDS-04F-045)
  5. Dec 18, 2025FDAFDA device clearance: Assert-IQ (DM5100)
  6. Dec 18, 2025CongressDisclosed sale of ABT — reported range $1,001 - $15,000
  7. Dec 19, 2025FDAFDA device approval: Volt™ PFA System
  8. Dec 19, 2025CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  9. Jan 22, 2026Company filing · Form 8-K · ResultsReported its results
  10. Jan 23, 2026Insider · First insider buy since Feb 2021CEO purchased ~$2.01M of ABT shares in the open market
  11. Jan 29, 2026CongressDisclosed purchase of ABT — reported range $1,001 - $15,000
  12. Feb 4, 2026Insider · 1 personInsiders: 2 purchases (~$1.1M)
  13. Feb 10, 2026CongressDisclosed partial sale of ABT — reported range $1,001 - $15,000
  14. Feb 13, 2026FDAFDA device clearance: Armada™ 14 NC PTA Catheter
  15. Feb 20, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
  16. Feb 23, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  17. Mar 2, 2026Insider · 6 peopleInsiders: 6 sales (~$485K)
  18. Mar 9, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  19. Mar 13, 2026FDAFDA device clearance: Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80
  20. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Abbott Laboratories

For Abbott Laboratories, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 6 Congress trade reports and 59 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABT page.

Other recent filings by Rep. Byron Donalds (FL19)

The full history of Rep. Byron Donalds (FL19) is on the profile page.

How this filing works

Explore the data

Other disclosures at Abbott Laboratories

Everything OQRO holds on this company is on its ABT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data